EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis and Biological Evaluation of Novel Oleanolic Acid Derivatives as Potential Anti-Leukemic Agents

Nefise Demir, Halilibrahim Ciftci iD, Khaled M Elamin iD, Mustafa Can iD, Belgin Sever iD

Life · 14.08.2026 · 16 (8) · 1335

DOI: 10.3390/life16081335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 14.08.2026. Verfasst von Nefise Demir und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanoscience and Nanotechnology, Izmir Kâtip Celebi University, Izmir 35620, Türkiye. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Scientific and Technological Research Council of Türkiye, Scientific and Technological Research Council of Turkey.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic myeloid leukemia (CML) and other leukemia subtypes remain significant hematological malignancies that require the development of novel therapeutic agents with improved efficacy and selectivity. This study aimed to design, synthesize, and evaluate novel oleanolic acid (OA) derivatives as potential anti-leukemic agents.

Methods

Structural modifications at the C-28 position afforded halogenated benzyl ester derivatives (MT-A–D), while aromatic acyl substitutions at the C-3 position generated derivatives NOA-1–16. The cytotoxic effects of the synthesized compounds were evaluated against K562, HL-60, Jurkat, and MT-2 leukemia cell lines and healthy PBMCs using the MTT assay. Apoptosis induction and ABL tyrosine kinase (TK) inhibition were also investigated. Molecular docking, MM/GBSA binding free energy calculations, and molecular dynamics (MD) simulations were performed to characterize ligand-enzyme interactions and binding stability.

Results

MT-A exhibited the highest activity against HL-60 cells (IC50 = 4.17 ± 0.65 μM), surpassing imatinib (IC50 = 13.34 ± 1.92 μM). NOA-8 was the most potent compound against Jurkat and MT-2 cells, with IC50 values of 6.81 ± 1.08 μM and 2.48 ± 0.88 μM, respectively. MT-A, MT-C, NOA-3, and NOA-8 displayed IC50 values above 300 μM in PBMCs, indicating favorable selectivity. MT-A and MT-C induced significant apoptosis in K562 cells, while kinase assays revealed moderate ABL TK inhibition by these compounds. Docking, MM/GBSA, and MD analyses supported stable binding of MT-A and MT-C within the ABL ATP-binding pocket.

Conclusions

MT-A, MT-C, NOA-3, and particularly NOA-8 emerged as promising anti-leukemic lead compounds with potent antiproliferative activity and favorable selectivity profiles, warranting further investigation for leukemia therapy.

Schlagwörter

Stichwörter der Autor:innen

apoptosisleukemiaoleanolic acid derivativestargeted drug design

Autor:innen und Institutionen

  • Department of Nanoscience and Nanotechnology, Izmir Kâtip Celebi University, Izmir 35620, Türkiye.
  • Department of Molecular Biology and Genetics, Burdur Mehmet Akif Ersoy University, Istiklal Campus, Burdur 15200, Türkiye.
  • Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan.
  • Department of Drug Discovery, Science Farm Ltd., Kumamoto 862-0976, Japan.
  • Global Center for Natural Products Research, Faculty of Life Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan.
  • Department of Bioengineering Sciences, Faculty of Engineering and Architecture, Izmir Kâtip Celebi University, Izmir 35620, Türkiye.

ORCID-Profile: Halilibrahim Ciftci, Khaled M Elamin, Mustafa Can, Belgin Sever

Förderung

  • The Scientific and Technological Research Council of Türkiye
  • Scientific and Technological Research Council of Turkey

Zitieren

APA

Demir, N., Ciftci, H., Elamin, K. M., Can, M., & Sever, B. (2026). Design, Synthesis and Biological Evaluation of Novel Oleanolic Acid Derivatives as Potential Anti-Leukemic Agents. Life, 16(8), 1335. https://doi.org/10.3390/life16081335

Vancouver

Demir N, Ciftci H, Elamin KM, Can M, Sever B. Design, Synthesis and Biological Evaluation of Novel Oleanolic Acid Derivatives as Potential Anti-Leukemic Agents. Life. 2026;16(8):1335. doi:10.3390/life16081335

BibTeX
@article{Demir2026,
  author = {Demir, Nefise and Ciftci, Halilibrahim and Elamin, Khaled M and Can, Mustafa and Sever, Belgin},
  title = {Design, Synthesis and Biological Evaluation of Novel Oleanolic Acid Derivatives as Potential Anti-Leukemic Agents},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {1335},
  doi = {10.3390/life16081335}
}
Kostenlos starten →